FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA granted a supplemental approval for Novo Nordisk's NOVOLIN R (human insulin), as part of a supplemental application submitted by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NOVOLIN R (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN R (HUMAN INSULIN)